Press Releases

 Filter by Provider

Miami, Florida, United States, 18th May 2025 – Natural Heaven, the ready-to-eat brand known for its pasta and rice alternatives made from hearts of palm, is entering an exciting new era. Backed by Ecuador’s largest food company, Pronaca, the brand is unveiling new packaging, upgraded recipes, and a mission to bring sustainable, clean-label convenience to U.S. families — with zero waste and no hidden ingredients.

Association of Medical Device Reprocessors issued the following statement:

Coastal proximity is a key driver in Australian internal migration, and non-bank lender Liberty has flexible home loans to help buyers chasing the surf-side lifestyle.

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced new data in two poster presentations at the ATS International Conference 2025. Data presented were from the Phase 3 IMPALA-2 clinical trial of molgramostim in aPAP and demonstrated that molgramostim reduces surfactant burden and improves health-related quality of life outcomes in patients with aPAP.

Marketing Veterans Offer Tried-and-True Formula for Independent Acts Seeking Real-World Results

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT) securities between February 25, 2025 and May 7, 2025, inclusive (the “Class Period”). Krispy Kreme investors have until July 15, 2025 to file a lead plaintiff motion.

Malvern, Worcestershire – Ramies Taxi Malvern is proud to announce its continued commitment to providing the most reliable, safe, and convenient 24-hour taxi service in Malvern and the surrounding areas. As the town grows and travel demands increase, Ramies Taxi remains the top choice for both locals and tourists seeking dependable transportation at any time of day or night.

9th Grade Algebra Made Easy has launched a new guide that aims to simplify high school algebraic concepts for students.

Max 2 You Media, specialists in helping smaller, local, and newer brands to rank at the top of the search results organically, has updated its popular "Done-For-You" content creation strategy to include 6 multimedia formats, such as blogs, podcasts, and streaming videos.

NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Dental implants are a strong, long-term way to replace missing or damaged teeth. But even though they're artificial, they can still experience wear and tear over time-just like natural teeth. In fact, failure to properly maintain dental implant restorations could mean they won't last a lifetime as they're designed to do. When getting dental implants in Valdosta, here are eight strategies to protect your implants from damage and wear.

In the wave of the cryptocurrency market, the recent trend of Dogecoin (DOGE) has attracted the attention of many investors. According to XBIT analysis, Dogecoin has just entered the key demand zone. Although it has fallen sharply by 10% from its high point, XBIT (dex Exchange) analysts believe that it is expected to recover to a new level in the short term, provided that the daily price low remains unchanged.

Robbins Geller Rudman & Dowd LLP announces that the Elevance Health class action lawsuit – captioned Miller v. Elevance Health, Inc., No. 25-cv-00923 (S.D. Ind.) – seeks to represent purchasers of Elevance Health, Inc. (NYSE: ELV) common stock and charges Elevance Health as well as certain of Elevance Health’s executives with violations of the Securities Exchange Act of 1934.

Qunatum Compute analysiert Echtzeitdaten, Qunatum Compute Fonds nutzen Zölle strategisch für sektorale Kapitalverlagerung.

Country music superstar Morgan Wallen is hitting the road in 2025 with his highly anticipated I’m The Problem Tour, promising unforgettable performances across North America. Fans eager to experience his chart-topping hits like “Whiskey Glasses,” “Last Night,” and new tracks from his upcoming album I’m The Problem can secure the best deals on concert tickets at CapitalCityTickets.com. By using the exclusive promo code CITY10, you can unlock additional savings on already affordable Morgan Wallen 2025 concert tickets. This guide will walk you through how to score the cheapest tickets online, highlight the tour schedule, and share tips to maximize your savings.

BitBadges, a multichain gated NFTs platform, has launched an affiliates program for anybody who wants to refer new users to the BitBadges ecosystem. BitBadges offers multi-chain token-gating, authentication, and decentralized identity as a service.

CHICAGO, IL / ACCESS Newswire / May 18, 2025 / The 2025 Taste of Asia Food Brand Summit made a powerful return to Chicago during the NRA Show week, bringing together over 200 leading brand founders, investors, system service providers, and supply chain professionals. Sponsored by MenuSifu, the leading POS and restaurant technology provider in North America, this closed-door summit provided a deep dive into how Asian food brands can achieve systematic replication and mainstream growth in North America.

Retail Shopping Center Owners Can Effortlessly Launch Easy-to-Use Wayfinding With Built-In Ad Revenue Opportunities Across Marketing Channels Through the Pylot® Platform With TouchSource's Turnkey Digital Wayfinding Solutions

Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) has updated its Restless Limb Syndrome (RLS) treatments for patients in Agoura Hills, CA.

At Home Sleep Apnea Testing has released a new guide detailing modern advancements in sleep apnea testing and highlighting more convenient options such as the WatchPAT One.

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today reported results from multi-site clinical experiences with IMVARIA’s diagnostic referral service, where pulmonologists send cases for AI-supported diagnostic evaluation of suspected Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Built by medical doctors with software engineering expertise, Fibresolve is the first ever FDA-authorized AI adjunctive diagnostic service of any type in lung fibrosis. Clinical data from use around the U.S. will be presented by pulmonary experts from Harvard’s Mass General Hospital at ATS 2025 International Conference, focusing on respiratory diseases, held on May 16-21, 2025 in San Francisco.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against MicroStrategy Incorporated d/b/a Strategy (“Strategy” or the “Company”) (NASDAQ: MSTR) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Virginia, and docketed under 25-cv-00861, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Strategy securities between April 30, 2024 and April 4, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or the “Company”) (NASDAQ: CGC) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-01877, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Canopy securities between May 30, 2024 and February 6, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Northrop Grumman Corporation (“Northrop Grumman” or the “Company”) (NYSE: NOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQ: NFE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Flowco Holdings Inc. (“Flowco” or the “Company”) (NYSE: FLOC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Amerant Bancorp Inc. (“Amerant” or the “Company”) (NYSE: AMTB).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Biohaven Ltd.  (“Biohaven” or the “Company”) (NYSE: BHVN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) and certain officers.   The class action, filed in the United States District Court for the Eastern District of Virginia , and docketed under 25-cv-00623, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc. (“ADTRAN” or the “Company”) (NASDAQ: ADTN).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Backblaze, Inc. (“Backblaze” or the “Company”) (NASDAQ: BLZE).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bakkt Holdings, Inc. (“Bakkt” or the “Company”) (NYSE: BKKT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Take-Two Interactive Software, Inc. (“Take-Two” or the “Company”) (NASDAQ: TTWO).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Uber Technologies, Inc.  (“Uber” or the “Company”) (NYSE: UBER).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. 

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against West Pharmaceutical Services, Inc. (“West” or the “Company”) (NYSE: WST).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.   

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or the “Company”) (NYSE: CLF).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Landstar System, Inc.  (“Landstar” or the “Company”) (NASDAQ: LSTR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Civitas Resources, Inc. (“Civitas” or the “Company”) (NYSE: CIVI) and certain officers.   The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv- 03791, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Civitas securities between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zenas BioPharma, Inc. (“Zenas” or the “Company”) (NASDAQ: ZBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Agilysys, Inc. (“Agilysys” or the “Company”) (NASDAQ: AGYS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Bitfarms Ltd. ("Bitfarms" or the "Company") (NASDAQ: BITF) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 25-cv-02630, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Bitfarms securities between March 21, 2023 and December 9, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Perpetua Resources Corp. (“Perpetua” or the “Company”) (NASDAQ: PPTA).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.